A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice

Objective: The objective of this study was to appraise the correlation and agreement of RAPID 3 with DAS 28 and CDAI in terms of measuring disease activity/severity and for monitoring response to treatment at 2 and 4 month follow up. Methods: 105 adult literate persons having rheumatoid arthritis a...

Full description

Saved in:
Bibliographic Details
Main Authors: Amit Kumar Das, Rathindra Nath Sarkar, Chandan Kumar Das, Ritasman Baisya, Urmimala Bhattacharjee, Pallab Biswas, Akashdip Bhattacharya
Format: Article
Language:English
Published: SAGE Publishing 2017-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=4;spage=209;epage=213;aulast=Das
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832543002846822400
author Amit Kumar Das
Rathindra Nath Sarkar
Chandan Kumar Das
Ritasman Baisya
Urmimala Bhattacharjee
Pallab Biswas
Akashdip Bhattacharya
author_facet Amit Kumar Das
Rathindra Nath Sarkar
Chandan Kumar Das
Ritasman Baisya
Urmimala Bhattacharjee
Pallab Biswas
Akashdip Bhattacharya
author_sort Amit Kumar Das
collection DOAJ
description Objective: The objective of this study was to appraise the correlation and agreement of RAPID 3 with DAS 28 and CDAI in terms of measuring disease activity/severity and for monitoring response to treatment at 2 and 4 month follow up. Methods: 105 adult literate persons having rheumatoid arthritis according to the 2010 ACR EULAR revised criteria were included. They were evaluated for disease activity by DAS 28, CDAI, and RAPID 3 scores. Response to treatment at 2 month and 4 month follow up was measured by these scores. Achievement of treatment target was defined as conversion from high/moderate disease activity at initial visit to low activity/remission at follow up visit. Result: The mean DAS 28 (0-10), CDAI (0-76) , RAPID 3 (0-30) were 4.73 , 16.72, 10.72 respectively. There was substantial agreement between DAS 28 and RAPID 3 severity categories (kappa = 0.959, P < 0.0001) and also between CDAI and RAPID 3. Conclusion: In a busy clinical setting, our study has shown usefulness of RAPID3 compared to the two most commonly used indices to assess disease activity in RA, both in terms of measuring quantitative disease activity as well as monitoring of treatment response at follow up visits.
format Article
id doaj-art-3614935c51ff4ff386de77f982278540
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2017-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-3614935c51ff4ff386de77f9822785402025-02-03T12:00:34ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012017-01-0112420921310.4103/injr.injr_87_17A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practiceAmit Kumar DasRathindra Nath SarkarChandan Kumar DasRitasman BaisyaUrmimala BhattacharjeePallab BiswasAkashdip BhattacharyaObjective: The objective of this study was to appraise the correlation and agreement of RAPID 3 with DAS 28 and CDAI in terms of measuring disease activity/severity and for monitoring response to treatment at 2 and 4 month follow up. Methods: 105 adult literate persons having rheumatoid arthritis according to the 2010 ACR EULAR revised criteria were included. They were evaluated for disease activity by DAS 28, CDAI, and RAPID 3 scores. Response to treatment at 2 month and 4 month follow up was measured by these scores. Achievement of treatment target was defined as conversion from high/moderate disease activity at initial visit to low activity/remission at follow up visit. Result: The mean DAS 28 (0-10), CDAI (0-76) , RAPID 3 (0-30) were 4.73 , 16.72, 10.72 respectively. There was substantial agreement between DAS 28 and RAPID 3 severity categories (kappa = 0.959, P < 0.0001) and also between CDAI and RAPID 3. Conclusion: In a busy clinical setting, our study has shown usefulness of RAPID3 compared to the two most commonly used indices to assess disease activity in RA, both in terms of measuring quantitative disease activity as well as monitoring of treatment response at follow up visits.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=4;spage=209;epage=213;aulast=DasClinical Disease Activity Index ScoreDisease Activity Score 28rheumatoid arthritisroutine assessment of Patient Index Data 3 score
spellingShingle Amit Kumar Das
Rathindra Nath Sarkar
Chandan Kumar Das
Ritasman Baisya
Urmimala Bhattacharjee
Pallab Biswas
Akashdip Bhattacharya
A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice
Indian Journal of Rheumatology
Clinical Disease Activity Index Score
Disease Activity Score 28
rheumatoid arthritis
routine assessment of Patient Index Data 3 score
title A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice
title_full A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice
title_fullStr A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice
title_full_unstemmed A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice
title_short A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice
title_sort comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice
topic Clinical Disease Activity Index Score
Disease Activity Score 28
rheumatoid arthritis
routine assessment of Patient Index Data 3 score
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=4;spage=209;epage=213;aulast=Das
work_keys_str_mv AT amitkumardas acomparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT rathindranathsarkar acomparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT chandankumardas acomparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT ritasmanbaisya acomparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT urmimalabhattacharjee acomparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT pallabbiswas acomparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT akashdipbhattacharya acomparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT amitkumardas comparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT rathindranathsarkar comparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT chandankumardas comparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT ritasmanbaisya comparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT urmimalabhattacharjee comparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT pallabbiswas comparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice
AT akashdipbhattacharya comparisonof3rheumatoidarthritisdiseaseactivityindicesinroutineclinicalpractice